Crake Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,929
Closed -$7.74M 17
2024
Q1
$7.74M Sell
14,929
-90,000
-86% -$44.8M 0.78% 15
2023
Q4
$49.5M Sell
104,929
-14,000
-12% -$6.47M 4.72% 10
2023
Q3
$51.8M Hold
118,929
7.36% 6
2023
Q2
$52.8M Hold
118,929
7.13% 7
2023
Q1
$54.7M Buy
+118,929
New +$56.6M 7.92% 6
2022
Q4
Sell
-55,325
Closed -$25.1M 8
2022
Q3
$25.1M Buy
55,325
+31,968
+137% +$15.3M 7.26% 5
2022
Q2
$11.3M Sell
23,357
-139,701
-86% -$69.1M 2.22% 11
2022
Q1
$80.1M Sell
163,058
-54,000
-25% -$24.7M 6.19% 6
2021
Q4
$101M Sell
217,058
-37,193
-15% -$15.6M 5.69% 8
2021
Q3
$94.8M Buy
254,251
+16,000
+7% +$6.08M 5.17% 6
2021
Q2
$91M Sell
238,251
-104,000
-30% -$39.7M 4.73% 9
2021
Q1
$123M Hold
342,251
3.72% 11
2020
Q4
$110M Sell
342,251
-68,008
-17% -$20.9M 4.1% 10
2020
Q3
$110M Buy
410,259
+236,000
+135% +$63.5M 5.84% 6
2020
Q2
$45.8M Buy
174,259
+2,300
+1% +$614K 4.49% 9
2020
Q1
$39M Sell
171,959
-76,391
-31% -$20.8M 7.96% 6
2019
Q4
$75M Buy
+248,350
New +$68.3M 15.16% 3

Other funds holding ELV

Crake Asset Management's ELV Position: Q2 2024 in Review

Crake Asset Management sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 14,929 shares — an estimated $7.74M sold.

Crake Asset Management first reported a position in ELV in Q4 2019 and held it in 17 quarters. The position peaked at $123M in Q1 2021. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Crake Asset Management reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Crake Asset Management sold 14,929 Elevance Health shares in Q2 2024, an estimated $7.74M.
  • Crake Asset Management first reported a position in Elevance Health in Q4 2019 and held it in 17 quarters.
  • Crake Asset Management's Elevance Health position peaked at $123M in Q1 2021.
  • 1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Crake Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.